DE10299003I2 - Phosphatbindende Polymere f}r orale Verabreichung - Google Patents

Phosphatbindende Polymere f}r orale Verabreichung

Info

Publication number
DE10299003I2
DE10299003I2 DE1994628122 DE69428122C DE10299003I2 DE 10299003 I2 DE10299003 I2 DE 10299003I2 DE 1994628122 DE1994628122 DE 1994628122 DE 69428122 C DE69428122 C DE 69428122C DE 10299003 I2 DE10299003 I2 DE 10299003I2
Authority
DE
Germany
Prior art keywords
phosphate
oral administration
binding polymers
polymers
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1994628122
Other languages
English (en)
Other versions
DE69428122D1 (de
DE69428122T2 (de
Inventor
Iii W Harry Mandeville
Stephen Randall Holmes-Farley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26802726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10299003(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of DE10299003I2 publication Critical patent/DE10299003I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DE1994628122 1993-08-11 1994-08-10 Phosphatbindende Polymere f}r orale Verabreichung Active DE10299003I2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10559193A 1993-08-11 1993-08-11
US08/238,458 US5496545A (en) 1993-08-11 1994-05-05 Phosphate-binding polymers for oral administration
PCT/US1994/009060 WO1995005184A2 (en) 1993-08-11 1994-08-10 Phosphate-binding polymers for oral administration

Publications (1)

Publication Number Publication Date
DE10299003I2 true DE10299003I2 (de) 2006-07-13

Family

ID=26802726

Family Applications (5)

Application Number Title Priority Date Filing Date
DE1994628122 Active DE10299003I2 (de) 1993-08-11 1994-08-10 Phosphatbindende Polymere f}r orale Verabreichung
DE2002199003 Pending DE10299003I1 (de) 1993-08-11 1994-08-10 Phosphatbindende Polymere fuer orale Verabreichung
DE122009000081C Pending DE122009000081I1 (de) 1993-08-11 1994-08-10 Phosphatbindende polymere für orale verabreichung
DE69434726T Expired - Lifetime DE69434726T2 (de) 1993-08-11 1994-08-10 Polymer zur therapeutischen Anwendung
DE69428122T Expired - Lifetime DE69428122T2 (de) 1993-08-11 1994-08-10 Phosphatbindende polymere für orale verabreichung

Family Applications After (4)

Application Number Title Priority Date Filing Date
DE2002199003 Pending DE10299003I1 (de) 1993-08-11 1994-08-10 Phosphatbindende Polymere fuer orale Verabreichung
DE122009000081C Pending DE122009000081I1 (de) 1993-08-11 1994-08-10 Phosphatbindende polymere für orale verabreichung
DE69434726T Expired - Lifetime DE69434726T2 (de) 1993-08-11 1994-08-10 Polymer zur therapeutischen Anwendung
DE69428122T Expired - Lifetime DE69428122T2 (de) 1993-08-11 1994-08-10 Phosphatbindende polymere für orale verabreichung

Country Status (16)

Country Link
US (1) US5496545A (de)
EP (3) EP1676581A3 (de)
JP (2) JP3113283B2 (de)
KR (1) KR100346766B1 (de)
AT (2) ATE324900T1 (de)
AU (1) AU689797B2 (de)
CA (3) CA2310960C (de)
DE (5) DE10299003I2 (de)
DK (2) DK0716606T3 (de)
ES (2) ES2161780T3 (de)
HK (2) HK1036753A1 (de)
LU (2) LU90884I2 (de)
NL (2) NL300080I1 (de)
NZ (1) NZ271826A (de)
PT (2) PT1133989E (de)
WO (1) WO1995005184A2 (de)

Families Citing this family (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692432B2 (en) * 1993-02-17 1998-06-11 British Technology Group Limited Polymeric compounds
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
GB9503061D0 (en) * 1995-02-16 1995-04-05 British Tech Group Polymeric compounds
DE19528524C2 (de) * 1995-08-03 1999-11-11 Hans Dietl Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
EP0793960B1 (de) * 1996-03-05 2001-08-01 Mitsubishi Chemical Corporation Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie
CN1230118A (zh) * 1996-07-19 1999-09-29 日研化学株式会社 高磷血症治疗剂
CA2269586A1 (en) * 1996-10-23 1998-04-30 The Dow Chemical Company Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
AU2446497A (en) * 1997-03-25 1998-10-20 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers combined with a calcium supplement for oral administration
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
AU2682499A (en) * 1998-02-17 1999-08-30 Dimitri R. Kioussis Anion binding polymers and the use thereof
AU3005599A (en) * 1998-03-19 1999-10-11 Geltex Pharmaceuticals, Inc. Continuous crosslinking of polymer gels
US6294163B1 (en) 1998-10-02 2001-09-25 Geltex Pharmaceuticals, Inc. Polymers containing guanidinium groups as bile acid sequestrants
JP4749649B2 (ja) * 1998-10-12 2011-08-17 中外製薬株式会社 リン酸結合性ポリマー
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
ATE366264T1 (de) * 1999-04-16 2007-07-15 Abbott Lab Verfahren zur herstellung von vernetzten polyallyaminderivaten
US6190649B1 (en) 1999-04-23 2001-02-20 Geltex Pharmaceuticals, Inc. Polyether-based bile acid sequestrants
US6180754B1 (en) 1999-09-03 2001-01-30 The Dow Chemical Company Process for producing cross-linked polyallylamine polymer
US6362266B1 (en) 1999-09-03 2002-03-26 The Dow Chemical Company Process for reducing cohesiveness of polyallylamine polymer gels during drying
WO2001025291A1 (en) * 1999-10-07 2001-04-12 University Of Maryland Sugar binding polymers and the use thereof
US20030202958A1 (en) * 1999-10-15 2003-10-30 Strickland Alan D. Dialysis solution including polyglycol osmotic agent
CA2382864A1 (en) * 1999-10-15 2001-04-26 The Dow Chemical Company Dialysis solution including polyglycol osmotic agent
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
ES2235969T3 (es) * 1999-10-19 2005-07-16 Genzyme Corporation Nucleo de comprimido polimerico por compresion directa.
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US20040059065A1 (en) * 2000-03-09 2004-03-25 Takeshi Goto Crosslinked anion-exchange resin or salt thereof
WO2001066607A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
AU2001241095A1 (en) 2000-03-13 2001-09-24 Hisamitsu Pharmaceutical Co. Inc. Preventives and/or remedies for hyperphosphatemia
WO2002032974A2 (en) * 2000-10-18 2002-04-25 Fujisawa Pharmaceutical Co., Ltd. Polymer and its use for the treatment and/or prevention of hyperphosphoremia
AU2002224109A1 (en) * 2000-11-28 2002-06-11 Mitsubishi Pharma Corporation Excretion accelerator for accumulative chlorine compound
CN100594933C (zh) * 2000-11-28 2010-03-24 田边三菱制药株式会社 抗肥胖剂和健康食品
AT409630B (de) * 2000-12-13 2002-09-25 Dsm Fine Chem Austria Gmbh Alkylierung von n-bzw. amino- oder ammoniumgruppen haltigen, vernetzten polymeren
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
WO2002066543A1 (en) * 2001-02-16 2002-08-29 Genzyme Corporation Method of drying a material having a cohesive phase
ATE331525T1 (de) * 2001-04-18 2006-07-15 Genzyme Corp Salzformarme polyallylamine
EP1923064B1 (de) 2001-04-18 2017-06-28 Genzyme Corporation Verwendung von Aminpolymeren zur Minderung des Serumglukosegehaltes
EP1379259A1 (de) 2001-04-18 2004-01-14 Genzyme Corporation Verfahren zur behandlung von syndrom x mit aliphatischen polyaminen
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
AU2002257145B2 (en) * 2001-04-18 2005-06-02 Genzyme Corporation Method for lowering serum glucose
MX2008011686A (es) * 2001-05-25 2010-05-27 Marathon Oil Co Inhibicion de sulfuracion del deposito utilizando una inyeccion de agua tratada.
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
JP2003033651A (ja) * 2001-07-24 2003-02-04 Chisso Corp 経口リン吸着剤及びそれを含む食品
TWI324519B (en) * 2001-07-30 2010-05-11 Mitsubishi Tanabe Pharma Corp Drugs for ameliorating postcibal hyperglycemia
US6600011B2 (en) 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
FR2833169B1 (fr) * 2001-12-07 2004-07-16 Oreal Composition filtrante contenant un derive de 1,3,5-triazine, un derive du dibenzoylmethane, et un derive de 2-hydroxybenzophenone aminosubstitue
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
ATE337326T1 (de) * 2002-03-19 2006-09-15 Genzyme Corp Hemmer des phosphattransports
AT411463B (de) 2002-09-03 2004-01-26 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von alkylierten n- bzw. amino-, ammonium- oder spirobicyclischen ammoniumgruppen haltigen, vernetzten polymeren
AU2003282867A1 (en) * 2002-10-22 2004-05-13 Genzyme Corporation Amine polymers for promoting bone formation
AT412473B (de) 2003-01-15 2005-03-25 Dsm Fine Chem Austria Gmbh Verfahren zur kontinuierlichen trocknung von n- bzw. amino-, ammonium- oder spirobicyclische ammoniumgruppen haltigen polymeren
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
WO2005082977A1 (en) * 2004-02-23 2005-09-09 E.I. Dupont De Nemours And Company Crosslinked polymers containing biomass derived materials
WO2005082978A1 (en) * 2004-02-23 2005-09-09 E.I. Dupont De Nemours And Company Preparation of crosslinked polymers containing biomass derived materials
CA2560927C (en) 2004-03-26 2013-05-14 Mitsubishi Pharma Corporation Insulin resistance-improving agent
CN103251571B (zh) 2004-03-30 2016-08-17 瑞立普萨公司 离子结合聚合物及其用途
US20050276781A1 (en) * 2004-06-09 2005-12-15 Ross Edward A Molecularly imprinted phosphate binders for therapeutic use
AU2005290229A1 (en) * 2004-09-24 2006-04-06 Biosphere Medical, Inc. Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof
DE602005020501D1 (de) * 2004-10-13 2010-05-20 Ilypsa Inc Vernetzte aminpolymere
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
JP4547620B2 (ja) * 2004-12-02 2010-09-22 日東紡績株式会社 架橋アリルアミン類重合体の製造方法
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
EP1830832A1 (de) * 2004-12-30 2007-09-12 Genzyme Corporation Zinkhaltige behandlungen für hyperphosphatämie
CN101163731A (zh) * 2005-02-23 2008-04-16 纳幕尔杜邦公司 使用α，ω-二官能醛糖二酰胺作为单体和交联剂的方法
JP2008533272A (ja) * 2005-03-16 2008-08-21 ユーエスヴィー リミテッド 架橋ポリアリルアミンポリマーの調製のための改良された方法
US8492432B2 (en) * 2005-08-17 2013-07-23 Hill's Pet Nutrition, Inc. Methods for the treatment of kidney disease
CA2620406A1 (en) * 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
KR101547925B1 (ko) * 2005-09-15 2015-08-27 젠자임 코포레이션 아민 중합체에 대한 샤셋 제형
AU2012205214B2 (en) * 2005-09-15 2015-05-21 Genzyme Corporation Formulation for Amine Polymers
GB2446077B (en) 2005-09-30 2010-10-13 Ilypsa Inc Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
JP2009510233A (ja) 2005-09-30 2009-03-12 レリプサ， インコーポレイテッド 架橋シェルを有するコア−シェルコンポジットを製造する方法および該方法によって生じたコア−シェルコンポジット
EP1945196A2 (de) * 2005-11-08 2008-07-23 Genzyme Corporation Magnesiumhaltige polymere für hyperphosphatämie
EP1973587B1 (de) 2005-12-12 2019-02-06 AllAccem, Inc. Verfahren und systeme zur herstellung von antimikrobiellen filmen und überzügen
ITRM20060204A1 (it) * 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
EP2016114A2 (de) * 2006-05-05 2009-01-21 Genzyme Corporation Aminkondensationspolymere als phosphatkomplexbildner
EP2039363B1 (de) 2006-06-16 2013-01-02 Mitsubishi Tanabe Pharma Corporation Mittel zur prävention und/oder behandlung von glomerulopathie
WO2008005217A2 (en) * 2006-07-05 2008-01-10 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
JP2009543869A (ja) * 2006-07-18 2009-12-10 ゲンズイメ コーポレーション アミンデンドリマー
WO2008018556A1 (en) 2006-08-09 2008-02-14 Mitsubishi Tanabe Pharma Corporation Tablet
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
CA2749074A1 (en) * 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
EP2066293A2 (de) 2006-09-29 2009-06-10 Genzyme Corporation Amid-dendrimer-zusammensetzungen
JP5535638B2 (ja) 2006-10-25 2014-07-02 ウィスコンシン アルムニ リサーチ ファンデイション リン酸塩吸収の低減方法
US20100143385A1 (en) 2006-10-26 2010-06-10 Mark Cook Methods for reducing phosphate absorption
US8163799B2 (en) * 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
JP2008169758A (ja) * 2007-01-11 2008-07-24 Bosch Corp ターボチャージャ駆動制御方法及びその装置
WO2008103847A2 (en) 2007-02-21 2008-08-28 Allaccem, Incorporated Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
US20100129309A1 (en) * 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
JP2010520285A (ja) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
US8034833B2 (en) * 2008-03-20 2011-10-11 Biolink Life Sciences, Inc. Phosphorus binder for treatment of renal disease
US20100166696A1 (en) * 2007-04-27 2010-07-01 Dhal Pradeep K Amido-amine dendrimer compositions
BRPI0813928A2 (pt) 2007-07-11 2014-12-30 Toray Industries Polialilamina reticulada, composição farmacêutica, agente terapêutico ou profilático para hiperfosfatemia, método terapêutico ou profilático para hiperfosfatemia, uso da polialilamina reticulada, e, composto para terapia ou profilaxia de hiperfosfatemia
EP2016947A1 (de) * 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Neuartiges Verfahren zur Herstellung vernetzter Poly(allylamin-)Polymere in einem einzigen Schritt
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
WO2009023544A2 (en) * 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
TWI468167B (zh) 2007-11-16 2015-01-11 威佛（國際）股份有限公司 藥學組成物
EP2217215A1 (de) * 2007-12-14 2010-08-18 Genzyme Corporation Beschichtete pharmazeutische zusammensetzungen
US8389640B2 (en) * 2008-04-15 2013-03-05 Lupin Limited Process for the preparation of cross-linked polyallylamine polymer
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US8404784B2 (en) * 2008-12-03 2013-03-26 Navinta Llc Manufacturing process of making polymeric amine salts
US20100166861A1 (en) * 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
WO2010086881A2 (en) 2009-01-22 2010-08-05 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
CA2765370A1 (en) 2009-06-16 2010-12-23 Watson Pharma Private Limited Processes for the preparation of sevelamer carbonate
US8673272B2 (en) * 2009-07-27 2014-03-18 Isp Investments Inc. Ultraviolet-absorbing compounds
JP5377265B2 (ja) * 2009-12-16 2013-12-25 一般財団法人川村理化学研究所 ポリマー／酒石酸結晶性ナノ複合体及びその製造方法
GB0921951D0 (en) * 2009-12-16 2010-02-03 Fujifilm Mfg Europe Bv Curable compositions and membranes
US8951177B2 (en) 2010-01-15 2015-02-10 Graphic Packaging International, Inc. Flight lug for octagonal cartons
AU2011220742B2 (en) 2010-02-24 2016-02-25 Relypsa, Inc. Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants
JP5717422B2 (ja) * 2010-11-30 2015-05-13 株式会社パイロットコーポレーション ゲル状組成物の製造方法
IT1404163B1 (it) * 2011-02-01 2013-11-15 Chemi Spa Processo per la preparazione di poliallilamine reticolate o loro sali farmaceuticamente accettabili
ES2563316T3 (es) 2011-02-09 2016-03-14 Synthon Bv Formas estabilizadas de envasado de sevelamer
CN102796262B (zh) * 2011-05-24 2014-11-12 北大方正集团有限公司 一种碳酸司维拉姆的制备方法
WO2013064193A1 (en) 2011-11-04 2013-05-10 Synthon Bv Pharmaceutical compositions comprising sevelamer
US20130123433A1 (en) 2011-11-14 2013-05-16 Formosa Laboratories, Inc. Method for preparing poly(allylamine) hydrochloride and derivatives therefrom
WO2013087237A1 (en) 2011-12-13 2013-06-20 Synthon Bv Purification of sevelamer and related polyallylamines
WO2013087238A1 (en) 2011-12-13 2013-06-20 Synthon Bv Preparation of sevelamer with reduced content of allylamine
CN102675510B (zh) * 2012-05-28 2014-04-02 诚达药业股份有限公司 司维拉姆的合成工艺
ES2471340B1 (es) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Composición farmacéutica oral para fármacos de elevada posología
EP2968165B1 (de) 2013-03-13 2023-09-13 Biosphere Medical, Inc. Zusammensetzungen und zugehörige verfahren für radioisotopenbindende mikropartikel
CN103446179B (zh) * 2013-05-14 2017-03-15 厦门绿洲安源投资管理有限公司 作为磷酸盐、脂肪酸和胆汁酸绑定螯合剂的双亲聚富勒烯树状交联聚阳离子凝胶的应用
PT3003327T (pt) 2013-06-05 2017-11-09 Tricida Inc Polímeros de ligação de protões para administração oral
DK3593808T3 (da) 2014-12-10 2021-02-01 Tricida Inc Proton-bindingspolymerer til oral indgivelse
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
CA2980472C (en) 2015-03-20 2023-08-29 Howard University Microcarriers, matrices and scaffolds for culturing mammalian cells and methods of manufacture
WO2016150342A1 (zh) 2015-03-20 2016-09-29 杨达志 多糖-聚氨共聚物及其在降低血浆中低密度脂蛋白浓度的应用
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
CN109153587A (zh) 2016-03-08 2019-01-04 技术研究及发展基金有限公司 来自盐水水产养殖系统的氮物质的消毒和去除
JP7071284B2 (ja) 2016-05-06 2022-05-18 トリシダ・インコーポレイテッド 酸塩基障害を処置するためのＨＣｌ結合性組成物およびその方法
KR20190084125A (ko) 2016-12-28 2019-07-15 후지필름 가부시키가이샤 질소 원자 함유 폴리머 또는 그 염의 유화액, 그 제조 방법, 및 입자의 제조 방법
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
WO2019078197A1 (ja) * 2017-10-16 2019-04-25 富士フイルム株式会社 高リン血症治療剤
AU2018352766B2 (en) * 2017-10-16 2021-09-23 Fujifilm Corporation Hyperphosphatemia treatment agent, and particles
US10479865B2 (en) 2017-11-01 2019-11-19 Strides Shasun Limited Process for the preparation of sevelamer carbonate
EP3703706A4 (de) * 2017-11-03 2022-04-27 Tricida Inc. Zusammensetzungen und verfahren zur behandlung von säure-basen-störungen
CN112047854B (zh) * 2020-10-20 2021-07-02 中国科学院长春应用化学研究所 一种n-乙烯基烷基酰胺的制备方法
EP4295836A1 (de) 2022-06-22 2023-12-27 Labomed Pharmaceutical Company S.A. Beutel mit einer flüssigen suspension eines sevelamersalzes
WO2024084076A1 (en) * 2022-10-20 2024-04-25 Universiteit Gent Method to prepare amidated polymers

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE580490A (fr) * 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3332841A (en) * 1961-10-04 1967-07-25 Lilly Co Eli Method of treating hyperacidity
DE1927336A1 (de) * 1968-06-17 1969-12-18 Upjohn Co Orale Dosierungsform zur Bekaempfung von Hypercholesterinaemie
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
DK136015B (da) * 1973-02-09 1977-08-01 Sandoz Ag Fremgangsmåde til fremstilling af en aluminiumhydrogel til anvendelse som phosphatbindingsmiddel.
AR206115A1 (es) * 1973-06-11 1976-06-30 Merck & Co Inc Procedimiento para preparar un polimero lineal no ramificado y no reticulado
US4205064A (en) * 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof
US4181718A (en) * 1975-12-29 1980-01-01 Mason Norbert S Polyanion-stabilized aluminum hydrogels
US4071478A (en) * 1976-06-07 1978-01-31 Merck & Co., Inc. Controlled partially cross-linked 3,3-ionenes
DE2741323A1 (de) * 1977-03-10 1978-09-14 Werner Klaus Konzack Raederfahrzeug
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
JPS5566513A (en) * 1978-11-14 1980-05-20 Ono Pharmaceut Co Ltd Drug for arteriosclerosis comprising high polymer compound as active constituent
US4247393A (en) * 1979-01-11 1981-01-27 Wallace Richard A Hemodialysis assist device
EP0055048B1 (de) * 1980-12-12 1985-04-03 Smith and Nephew Associated Companies p.l.c. Polymere, deren Herstellung und Verwendungen
JPS6090243A (ja) * 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
OA08092A (fr) * 1984-05-11 1987-03-31 Bristol Myers Co Novel bile sequestrant resin and uses.
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
JPS62132830A (ja) * 1985-12-05 1987-06-16 Teijin Ltd 徐放性医薬品組成物
EP0350714B1 (de) * 1988-07-13 1994-03-09 Collaborative Biomedical Products Inc. Gewebe-Immobilisierungs- und Zellkultursystem und Verfahren zum Anbringen biologisch wirksamer Teile an einem Substrat
KR900701285A (ko) * 1988-08-26 1990-12-01 로버어트 에이 아미테이지 미세-구슬상 콜레스티폴 염산염
GB8829835D0 (en) * 1988-12-21 1989-02-15 Smith Kline French Lab Compounds
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
JPH0687974B2 (ja) * 1990-03-27 1994-11-09 忠一 平山 発熱物質の吸着材料
JPH0424180A (ja) * 1990-05-16 1992-01-28 Daikin Ind Ltd クローラ式小型運搬機
AU659106B2 (en) * 1990-11-06 1995-05-11 Fgn, Inc. Method for treating colonic polyps by the use of esters and amides of substituted phenyl and pyridyl amino carboxylates
IE914179A1 (en) * 1990-12-07 1992-06-17 Ici Plc Nitrogen derivatives
JP2785529B2 (ja) * 1991-08-21 1998-08-13 日東紡績株式会社 エタノール徐放剤およびそれを用いた食品保存用組成物
EP0534304A1 (de) * 1991-09-21 1993-03-31 Hoechst Aktiengesellschaft Cycloalkylierte Polyethyleniminderivate und ihre Verwendung als Hypolipidämika
SE470006B (sv) * 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
WO1993014127A1 (en) * 1992-01-21 1993-07-22 University Of Utah Method and composition for heparin binding using polyaminocations covalently immobilised on polymeric surfaces with polyethylene oxide spacers
AU4225993A (en) * 1992-05-06 1993-11-29 Isp Investments Inc. Polymers of vinyl-pyrrolidone and aminoalkyl acrylamides
DE4227019A1 (de) * 1992-08-14 1994-02-17 Geckeler Kurt E Priv Doz Dr Herstellung und Modifikation von Materialien auf der Basis von Amino- oder Amidpolymeren
HUT72658A (en) * 1992-08-20 1996-05-28 Du Pont Crosslinked polymeric ammonium salts and pharmaceutical compositions containing them
US5302531A (en) * 1992-10-22 1994-04-12 Miles Inc. Composition for the semiquantitative determination of specific gravity of a test sample
AU692432B2 (en) * 1993-02-17 1998-06-11 British Technology Group Limited Polymeric compounds
EP0706399A4 (de) * 1993-06-02 1998-08-12 Geltex Pharma Inc Präparate und verfahren zur entfernung von gallensalzen

Also Published As

Publication number Publication date
DK0716606T3 (da) 2001-12-17
DE122009000081I1 (de) 2010-04-29
AU689797B2 (en) 1998-04-09
JP2001055336A (ja) 2001-02-27
ATE204756T1 (de) 2001-09-15
DE10299003I1 (de) 2002-05-08
US5496545A (en) 1996-03-05
CA2169356A1 (en) 1995-02-23
DK1133989T3 (da) 2006-09-11
NZ271826A (en) 2000-06-23
ATE324900T1 (de) 2006-06-15
DE69434726D1 (de) 2006-06-08
DE69434726T2 (de) 2007-01-18
LU90884I2 (en) 2002-03-25
KR100346766B1 (ko) 2003-10-04
CA2310960C (en) 2003-05-27
DE69428122D1 (de) 2001-10-04
AU7560794A (en) 1995-03-14
CA2169356C (en) 2000-07-04
WO1995005184A3 (en) 1995-03-23
NL300080I1 (nl) 2002-04-02
LU91629I2 (fr) 2011-08-25
CA2402590A1 (en) 1995-02-23
EP1133989A2 (de) 2001-09-19
CA2310960A1 (en) 1995-02-23
KR960703607A (ko) 1996-08-31
EP1133989B1 (de) 2006-05-03
ES2161780T3 (es) 2001-12-16
HK1009243A1 (en) 1999-05-28
PT716606E (pt) 2002-02-28
NL300428I1 (nl) 2010-02-01
JPH09504782A (ja) 1997-05-13
PT1133989E (pt) 2006-08-31
EP1676581A3 (de) 2008-12-03
EP1676581A2 (de) 2006-07-05
WO1995005184A2 (en) 1995-02-23
HK1036753A1 (en) 2002-01-18
JP3113283B2 (ja) 2000-11-27
EP1133989A3 (de) 2004-05-12
EP0716606A1 (de) 1996-06-19
ES2260154T3 (es) 2006-11-01
EP0716606B1 (de) 2001-08-29
DE69428122T2 (de) 2002-04-18
EP0716606A4 (de) 1999-12-22

Similar Documents

Publication Publication Date Title
DE10299003I2 (de) Phosphatbindende Polymere f}r orale Verabreichung
WO1996039156A3 (en) Phosphate-binding polymers for oral administration
DE69432559D1 (de) Verwendung von eisenbindenden polymeren zur herstellung eines medikaments zur oralen verabreichung
BG101118A (en) Therapeutical compounds
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
BR9807076A (pt) Tratamento de esclerose múltipla mediante ingestão ou inalação de copolìmero-1
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
KR910700059A (ko) 위장관의 장해 약제치료용 디메틸폴리실옥산사용
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
MY114084A (en) Phosphate - binding polymers for oral administration
MX9705305A (es) Polimeros fijadores de fosfato para administracion oral.
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
CA2122908A1 (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
TR199701605A2 (xx) S�lfonamid-substit�e edilmi� bile�ikler
ATE298235T1 (de) Heilmittel und prophylaxe von störungen der intestinalen schleimhäute
CA2239420A1 (en) Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
DE60040856D1 (de) Lactalbumin zur kurativen Behandlung von Magengeschwüren
CA2239422A1 (en) Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
GR920100469A (el) Ανταγωνιστές 5-ΗΤ4 βενζοδιοξανο οξαδιαζόλης.